MXPA02000529A - Nuevos compuestos de ciclohepteno, un proceso para su preparacion y las composiciones farmaceuticas que los contienen. - Google Patents
Nuevos compuestos de ciclohepteno, un proceso para su preparacion y las composiciones farmaceuticas que los contienen.Info
- Publication number
- MXPA02000529A MXPA02000529A MXPA02000529A MXPA02000529A MXPA02000529A MX PA02000529 A MXPA02000529 A MX PA02000529A MX PA02000529 A MXPA02000529 A MX PA02000529A MX PA02000529 A MXPA02000529 A MX PA02000529A MX PA02000529 A MXPA02000529 A MX PA02000529A
- Authority
- MX
- Mexico
- Prior art keywords
- heteroaryl
- unsubstituted
- substituted
- aryl
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 125000001162 cycloheptenyl group Chemical class C1(=CCCCCC1)* 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000003528 protein farnesyltransferase inhibitor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Abstract
Se describen los compuestos de la formula (I): (Ver formula) - X representa un enlace o un grupo alquileno, CO, S (O)n, -S (O)n - A1 , - CO-A1- , -A1-S(O)n -A??1 o -A1- CO- A??1 -, - Y representa un grupo arilo, heteroarilo, cicloalquilo o heterocicloalquilo, cada uno sustituido o no sustituido, e R1 , R2 , R3 y R4 cada uno independientemente de los otros representa un atomo de hidrogeno o un grupo arilo, heteroarilo, cicloalquilo o heterocicloalquilo, cada uno no sustituido o sustituido, o R1, R2 , R3 y R4, tomados en pares, conjuntamente forman un enlace, o forman un anillo de benceno fusionado o un heterociclo aromatico fusionado o parcialmente insaturado, T representa un grupo - CH(R5)-, -N(R5)- o -N(R5)CO-, o heteroarilo no sustituido o sustituido, V representa un atomo de hidrogeno o un grupo arilo A2 representa un grupo [C(R6) (R??6)]p, R7 y R8 son como se definen en la descripcion, Los medicamentos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0100641A FR2819509B1 (fr) | 2001-01-18 | 2001-01-18 | Nouveaux composes cycloheptene, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02000529A true MXPA02000529A (es) | 2004-11-01 |
Family
ID=8858954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02000529A MXPA02000529A (es) | 2001-01-18 | 2002-01-15 | Nuevos compuestos de ciclohepteno, un proceso para su preparacion y las composiciones farmaceuticas que los contienen. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6638962B2 (es) |
| EP (1) | EP1225170A3 (es) |
| JP (1) | JP2002265448A (es) |
| KR (1) | KR100483360B1 (es) |
| CN (1) | CN1166641C (es) |
| AR (1) | AR034015A1 (es) |
| AU (1) | AU781680B2 (es) |
| BR (1) | BR0200114A (es) |
| CA (1) | CA2367306C (es) |
| EA (1) | EA004859B1 (es) |
| FR (1) | FR2819509B1 (es) |
| HU (1) | HUP0200204A3 (es) |
| MX (1) | MXPA02000529A (es) |
| NO (1) | NO322100B1 (es) |
| NZ (1) | NZ516684A (es) |
| PL (1) | PL351732A1 (es) |
| ZA (1) | ZA200200471B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3698797A1 (en) | 2017-10-16 | 2020-08-26 | Tsinghua University | Mevalonic acid pathway inhibitor and pharmaceutical composition thereof |
| CN114573501A (zh) * | 2022-03-02 | 2022-06-03 | 河南阿尔法医药科技有限公司 | 一种可规模化生产2,2′:6′,2″-三联吡啶-4′-甲醛的方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117580A0 (en) * | 1995-03-29 | 1996-07-23 | Merck & Co Inc | Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them |
| US5710171A (en) * | 1995-05-24 | 1998-01-20 | Merck & Co., Inc. | Bisphenyl inhibitors of farnesyl-protein transferase |
| US6028201A (en) * | 1996-01-30 | 2000-02-22 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| AU2589497A (en) | 1996-03-29 | 1997-10-22 | Trustees Of The University Of Pennsylvania, The | Constrained cd4 peptides and methods of using the same |
| EP0891351A1 (en) * | 1996-04-03 | 1999-01-20 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| JP2000508631A (ja) * | 1996-04-03 | 2000-07-11 | メルク エンド カンパニー インコーポレーテッド | ファルネシルタンパク質トランスフェラーゼの阻害剤 |
| US5922883A (en) * | 1996-04-03 | 1999-07-13 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| JP2001519766A (ja) * | 1996-04-03 | 2001-10-23 | メルク エンド カンパニー インコーポレーテッド | ファルネシルタンパク質トランスフェラーゼの阻害剤 |
| JP2000507595A (ja) * | 1996-04-03 | 2000-06-20 | メルク エンド カンパニー インコーポレーテッド | ファルネシルプロテイントランスフェラーゼの阻害剤 |
| AU8921298A (en) * | 1997-08-27 | 1999-03-16 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| EP1025089A1 (en) * | 1997-10-22 | 2000-08-09 | Zeneca Limited | Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
-
2001
- 2001-01-18 FR FR0100641A patent/FR2819509B1/fr not_active Expired - Fee Related
-
2002
- 2002-01-15 MX MXPA02000529A patent/MXPA02000529A/es active IP Right Grant
- 2002-01-16 US US10/050,666 patent/US6638962B2/en not_active Expired - Fee Related
- 2002-01-16 EP EP02290101A patent/EP1225170A3/fr not_active Withdrawn
- 2002-01-16 PL PL02351732A patent/PL351732A1/xx not_active Application Discontinuation
- 2002-01-17 EA EA200200048A patent/EA004859B1/ru not_active IP Right Cessation
- 2002-01-17 BR BR0200114-4A patent/BR0200114A/pt not_active IP Right Cessation
- 2002-01-17 CA CA002367306A patent/CA2367306C/fr not_active Expired - Fee Related
- 2002-01-17 NO NO20020262A patent/NO322100B1/no unknown
- 2002-01-17 NZ NZ516684A patent/NZ516684A/xx unknown
- 2002-01-17 CN CNB021020426A patent/CN1166641C/zh not_active Expired - Fee Related
- 2002-01-18 JP JP2002009645A patent/JP2002265448A/ja active Pending
- 2002-01-18 AU AU11937/02A patent/AU781680B2/en not_active Ceased
- 2002-01-18 AR ARP020100173A patent/AR034015A1/es unknown
- 2002-01-18 KR KR10-2002-0002972A patent/KR100483360B1/ko not_active Expired - Fee Related
- 2002-01-18 ZA ZA200200471A patent/ZA200200471B/xx unknown
- 2002-01-18 HU HU0200204A patent/HUP0200204A3/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1365973A (zh) | 2002-08-28 |
| CN1166641C (zh) | 2004-09-15 |
| CA2367306C (fr) | 2006-07-11 |
| EP1225170A3 (fr) | 2002-08-28 |
| PL351732A1 (en) | 2002-07-29 |
| AU1193702A (en) | 2002-07-25 |
| AU781680B2 (en) | 2005-06-09 |
| US6638962B2 (en) | 2003-10-28 |
| NO322100B1 (no) | 2006-08-14 |
| US20020156113A1 (en) | 2002-10-24 |
| NZ516684A (en) | 2003-06-30 |
| EP1225170A2 (fr) | 2002-07-24 |
| EA200200048A1 (ru) | 2002-08-29 |
| CA2367306A1 (fr) | 2002-07-18 |
| HUP0200204A2 (hu) | 2002-12-28 |
| AR034015A1 (es) | 2004-01-21 |
| HK1048471A1 (en) | 2003-04-04 |
| EA004859B1 (ru) | 2004-08-26 |
| BR0200114A (pt) | 2002-10-22 |
| KR20020062212A (ko) | 2002-07-25 |
| KR100483360B1 (ko) | 2005-04-15 |
| HU0200204D0 (en) | 2002-03-28 |
| FR2819509A1 (fr) | 2002-07-19 |
| NO20020262L (no) | 2002-07-19 |
| ZA200200471B (en) | 2002-07-22 |
| NO20020262D0 (no) | 2002-01-17 |
| FR2819509B1 (fr) | 2004-04-16 |
| JP2002265448A (ja) | 2002-09-18 |
| HUP0200204A3 (en) | 2003-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3873612D1 (de) | Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| DK0562956T3 (da) | Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| ATE557002T1 (de) | Verbindungen mit calcimimetischer wirkung | |
| CY1110904T1 (el) | Φαρμακευτικως ενεργα παραγωγα βενζοσουλφοναμιδιου ως αναστολεις πρωτεϊνικων κινασων jun | |
| MXPA02003199A (es) | Derivados de sulfonamida farmaceuticamente activos. | |
| DK1233953T3 (da) | Nye benzoethiadiazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende samme | |
| DE68926981D1 (de) | Cephemverbindungen und Verfahren zu ihrer Herstellung | |
| ES2153019T3 (es) | Derivados de benzo-dioxano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| MXPA02000529A (es) | Nuevos compuestos de ciclohepteno, un proceso para su preparacion y las composiciones farmaceuticas que los contienen. | |
| AR029001A1 (es) | Derivados de bencil-3,4-metilendioxicinamico y el uso de los mismos para la manufactura de un medicamento | |
| HUP0301553A2 (hu) | Gyógyászati készítmények és alkalmazásuk neurológiai rendellenességek kezelésére | |
| DE69710909D1 (de) | Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
| GEP20063759B (en) | Novel Benzothiazine and Benzothiadiazine Derivatives, Method for Preparing Same and Pharmaceutical Compositions Containing Same | |
| EA200000374A2 (ru) | Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции | |
| EA200101204A1 (ru) | Новые бициклические соединения аминопиразинона, способ их получения и содержащие их фармацевтические композиции | |
| ATE288910T1 (de) | Substituierte alkylaminopyridazinonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| EA200000527A2 (ru) | Новые бициклические амино-пиразиноновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
| ATE239021T1 (de) | Metalloproteaseinhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| GEP20063757B (en) | Novel Benzothiazine and Benzothiadiazine Derivatives, Method for Preparing Same and Pharmaceutical Compositions Containing Same | |
| HUT69166A (en) | Process to preparare pharmaceutical compns. to prevent and to cure ulcus | |
| DK0611755T3 (da) | Hidtil ukendte (cyklohexyl)alkenforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| DK460789D0 (da) | 2-aminoacetamidderivater | |
| TH13254A (th) | ฟธาแลซีนชนิดใหม่ที่ประกอบด้วยอีเธอร์หรือไธโออีเธอร์ที่ตำแหน่ง 1-และกรรมวิธีการเตรียม | |
| ZA933942B (en) | Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them | |
| TH23095A (th) | อนุพันธ์พิรโรโลคาร์บาโซล ซึ่งใช้เป็นสารเคมีรักษาโรค |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |